| Title |
Epidemiology of idiopathic pulmonary fibrosis
|
|---|---|
| Published in |
Clinical Epidemiology, November 2013
|
| DOI | 10.2147/clep.s54815 |
| Pubmed ID | |
| Authors |
Brett Ley, Harold R Collard |
| Abstract |
Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that occurs in adults and has a poor prognosis. Its epidemiology has been difficult to study because of its rarity and evolution in diagnostic and coding practices. Though uncommon, it is likely underappreciated both in terms of its occurrence (ie, incidence, prevalence) and public health impact (ie, health care costs and resource utilization). Incidence and mortality appear to be on the rise, and prevalence is expected to increase with the aging population. Potential risk factors include occupational and environmental exposures, tobacco smoking, gastroesophageal reflux, and genetic factors. An accurate understanding of its epidemiology is important, especially as novel therapies are emerging. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iceland | 1 | 33% |
| New Zealand | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 283 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Japan | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 278 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 39 | 14% |
| Student > Master | 35 | 12% |
| Researcher | 31 | 11% |
| Student > Ph. D. Student | 31 | 11% |
| Other | 30 | 11% |
| Other | 42 | 15% |
| Unknown | 75 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 31% |
| Biochemistry, Genetics and Molecular Biology | 34 | 12% |
| Agricultural and Biological Sciences | 30 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 3% |
| Chemistry | 6 | 2% |
| Other | 33 | 12% |
| Unknown | 83 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#1,740,027
of 24,981,585 outputs
Outputs from Clinical Epidemiology
#76
of 778 outputs
Outputs of similar age
#15,941
of 220,628 outputs
Outputs of similar age from Clinical Epidemiology
#4
of 20 outputs
Altmetric has tracked 24,981,585 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 778 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 220,628 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.